-melanoma skin cancer (NMSC) in the United States costs Medicare more than $400 million per year. 5 , 6 Furthermore, the incidence of this common malignancy is rising rapidly. 1 , 7 – 13 BCCs are at least 2 times more common than squamous cell carcinomas (SCCs
Christopher K. Bichakjian, Thomas Olencki, Sumaira Z. Aasi, Murad Alam, James S. Andersen, Daniel Berg, Glen M. Bowen, Richard T. Cheney, Gregory A. Daniels, L. Frank Glass, Roy C. Grekin, Kenneth Grossman, Susan A. Higgins, Alan L. Ho, Karl D. Lewis, Daniel D. Lydiatt, Kishwer S. Nehal, Paul Nghiem, Elise A. Olsen, Chrysalyne D. Schmults, Aleksandar Sekulic, Ashok R. Shaha, Wade L. Thorstad, Malika Tuli, Marshall M. Urist, Timothy S. Wang, Sandra L. Wong, John A. Zic, Karin G. Hoffmann, and Anita Engh
Tejaswi Mudigonda, Daniel J. Pearce, Brad A. Yentzer, Phillip Williford, and Steven R. Feldman
N on-melanoma skin cancers (NMSCs), characterized by malignant growth of the epithelial layer or external surface of the skin, are the most prevalent form of skin cancer in the United States. 1 Since the 1960s, the incidence of NMSC has increased
Marcy Neuburg
transplantation . Transplant Proc 1993 ; 25 : 1383 – 1384 . 5. Bouwes Bavinck JN Hardie DR Green A . The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study . Transplantation 1996 ; 61 : 715 – 721
Sari M. Fien and Allan R. Oseroff
-melanoma skin cancer cells . Br J Dermatol 2006 ; 154 ( suppl 1 ): 16 – 21 . 9. Oseroff AR Shieh S Frawley NP . Treatment of diffuse basal cell carcinomas and basaloid follicular hamartomas in nevoid basal cell carcinoma syndrome by wide-area 5
Stanley J. Miller, Murad Alam, James Andersen, Daniel Berg, Christopher K. Bichakjian, Glen Bowen, Richard T. Cheney, L. Frank Glass, Roy C. Grekin, Anne Kessinger, Nancy Y. Lee, Nanette Liegeois, Daniel D. Lydiatt, Jeff Michalski, William H. Morrison, Kishwer S. Nehal, Kelly C. Nelson, Paul Nghiem, Thomas Olencki, Clifford S. Perlis, E. William Rosenberg, Ashok R. Shaha, Marshall M. Urist, Linda C. Wang, and John A. Zic
Overview Basal and squamous cell skin cancers, collectively known as non-melanoma skin cancers (NMSC), are the most common skin cancers. 1 , 2 More than 1 million cases of NMSC are estimated to be diagnosed each year in the United States and
Shoko Mori, Cristian Navarrete-Dechent, Tatyana A. Petukhova, Erica H. Lee, Anthony M. Rossi, Michael A. Postow, Lara A. Dunn, Benjamin R. Roman, Vivian T. Yin, Daniel G. Coit, Travis J. Hollmann, Klaus J. Busam, Kishwer S. Nehal, and Christopher A. Barker
Skin cancer is the most common form of cancer in the United States. The incidence of nonmelanoma skin cancer (NMSC), such as basal cell and squamous cell carcinomas, has increased from an estimated 3.5 million cases in 2006 to 5.4 million cases in
Thomas Olencki
We need to change direction on therapies for unresectable or metastatic nonmelanoma skin cancers, pronounced Thomas Olencki, DO, Clinical Professor of Internal Medicine and Vice Chair of the Division of Medical Oncology, The Ohio State University
Stefanie L. Thorsness, Azael Freites-Martinez, Michael A. Marchetti, Cristian Navarrete-Dechent, Mario E. Lacouture, and Emily S. Tonorezos
neoplasms. Nonmelanoma skin cancer (NMSC), principally basal cell carcinoma (BCC), is the most common subsequent neoplasm arising in childhood cancer survivors, occurring in 1% to 9% of survivors and accounting for 41% to 58% of all subsequent neoplasms. 3
Vanderbilt-Ingram Cancer Center
Basal cell and squamous cell skin cancers, collectively known as non-melanoma skin cancers (NMSCS), are the most common skin cancers. More than 1 million cases of NMSC are estimated to be diagnosed each year in the United States and their incidence is rising rapidly. Although rarely metastatic, basal cell and squamous cell cancers can produce substantial local destruction and disfigurement and may involve extensive areas of soft tissue, cartilage, and bone. Updates in the 2007 guidelines include changes to the principles of treatment for both basal cell and squamous cell skin cancers and changes in the consideration of radiotherapy.
For the most recent version of the guidelines, please visit NCCN.org
Basal cell and squamous cell skin cancers are the most common human cancers. They were estimated to have an incidence of more than one million cases in the United States in 2003. Although rarely metastatic, basal cell and squamous cell cancers can produce significant local destruction and disfigurement and may involve extensive areas of soft tissue, cartilage, and bone. The estimated annual cost of treating these two diseases in the United States exceeds $500 million.
For the most recent version of the guidelines, please visit NCCN.org
